168 related articles for article (PubMed ID: 18551075)
1. OX40 controls islet allograft tolerance in CD154 deficient mice by regulating FOXP3+ Tregs.
Chen M; Xiao X; Demirci G; Li XC
Transplantation; 2008 Jun; 85(11):1659-62. PubMed ID: 18551075
[TBL] [Abstract][Full Text] [Related]
2. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Gao W; Demirci G; Strom TB; Li XC
Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
4. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
[TBL] [Abstract][Full Text] [Related]
6. NK cells promote islet allograft tolerance via a perforin-dependent mechanism.
Beilke JN; Kuhl NR; Van Kaer L; Gill RG
Nat Med; 2005 Oct; 11(10):1059-65. PubMed ID: 16155578
[TBL] [Abstract][Full Text] [Related]
7. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the OX40 ligand prolongs corneal allograft survival.
Hattori T; Usui Y; Okunuki Y; Sonoda Y; Usui M; Takada E; Mizuguchi J; Yagita H; Okumura K; Akiba H; Takeuchi M
Eur J Immunol; 2007 Dec; 37(12):3597-604. PubMed ID: 18022861
[TBL] [Abstract][Full Text] [Related]
9. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
Beilke J; Johnson Z; Kuhl N; Gill RG
Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
[TBL] [Abstract][Full Text] [Related]
10. Critical role of OX40 in CD28 and CD154-independent rejection.
Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.
Feng G; Wood KJ; Bushell A
Transplantation; 2008 Aug; 86(4):578-89. PubMed ID: 18724229
[TBL] [Abstract][Full Text] [Related]
12. Critical, but conditional, role of OX40 in memory T cell-mediated rejection.
Vu MD; Clarkson MR; Yagita H; Turka LA; Sayegh MH; Li XC
J Immunol; 2006 Feb; 176(3):1394-401. PubMed ID: 16424166
[TBL] [Abstract][Full Text] [Related]
13. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
[TBL] [Abstract][Full Text] [Related]
14. Foxp3 as a marker of tolerance induction versus rejection.
Zhang GY; Hu M; Wang YM; Alexander SI
Curr Opin Organ Transplant; 2009 Feb; 14(1):40-5. PubMed ID: 19337145
[TBL] [Abstract][Full Text] [Related]
15. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection.
Johnson Z; Beilke J; Pietra B; Kelly B; Gill RG
Transplant Proc; 2004 May; 36(4):1171-2. PubMed ID: 15194405
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
[TBL] [Abstract][Full Text] [Related]
17. Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance.
Kim YS; Yang SH; Kang HG; Seong EY; Lee SH; Gao W; Kenny J; Zheng XX; Strom TB
Int Immunol; 2006 Dec; 18(12):1771-7. PubMed ID: 17068105
[TBL] [Abstract][Full Text] [Related]
18. Islet allograft tolerance in the absence of invariant natural killer T cells.
Chu X; Kilpatrick E; Xiao X; Liu W; Demirci G; Exley M; Li XC
Clin Immunol; 2011 Dec; 141(3):268-72. PubMed ID: 21996456
[TBL] [Abstract][Full Text] [Related]
19. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
Demirci G; Strom TB; Li XC
J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
[TBL] [Abstract][Full Text] [Related]
20. Peri-graft porcine-specific CD4
Yoon IH; Chung H; Kim HJ; Nam HY; Shin JS; Kim YH; Park CG
Xenotransplantation; 2019 Sep; 26(5):e12533. PubMed ID: 31111577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]